NTproBNP as a marker of rejection in pediatric heart transplant recipients

Pediatric Transplantation

Volumn 16, Issue 4, 2012, Pages 335-339

  Knecht, Kenneth R ^a,c   Alexander, Molly L ^b   Swearingen, Christopher J ^a   Frazier, Elizabeth A ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b HARDING UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

heart transplantation; NTproBNP; pediatrics; transplant rejection

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

CARDIAC GRAFT REJECTION; CHILD; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PEDIATRIC SURGERY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT;

EID: 84861199389     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01659.x     Document Type: Review

References (20)

1. Canter CE, Kirlin JK, eds. Pediatric Heart Transplantation, ISHLT Monograph Series. Philadelphia, PA: Elsevier, 2007.
2. Kirk R, Edwards LB, Kucheryavaya AY, et al., The Registry of the International Society for Heart and Lung Transplantation: Fourteenth pediatric heart transplantation report-2011. J Heart Lung Transplant 2011: 30: 1095-1103.
3. Hall C,. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004: 6: 257-260. (Pubitemid 38253043)
4. Park MH, Uber PA, Scott RL, Mehra MR,. B-type natriuretic peptide in heart transplantation: An important marker of allograft performance. Heart Fail Rev 2003: 8: 359-363. (Pubitemid 37548057)
5. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR,. Usefulness of b-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 2002: 90: 1326-1329. (Pubitemid 35449478)
6. Mehra MR, Uber PA, Potluri S, Ventura HO, Scottt RL, Park MH,. Usefulness of an elevated b-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 2004: 94: 454-458. (Pubitemid 39119994)
7. Mehra MR, Uber PA, Walther D, et al., Gene expression profiles and b-type natriuretic peptide elevation in heart transplantation: More than a hemodynamic marker. Circulation 2006: 114: I21-I26. (Pubitemid 44297123)
8. Ambrosi P, Oddoze C, Ribéri A, et al., Usefulness of n-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am J Cardiol 2004: 94: 1585-1587. (Pubitemid 40268472)
9. Behr TM, Feucht HE, Richter K, et al., Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999: 18: 904-912. (Pubitemid 29469451)
10. Lemley KV,. Estimating GFR in children: Schwartz redux. Nature 2009: 5: 310-311.
11. Schowengerdt KO, Fricker FJ, Bahjat KS, Kuntz ST,. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection. Transplantation 2000: 69: 2102-2107. (Pubitemid 30395042)
12. Lindblade CL, Chun DS, Darragh RK, Caldwell RL, Murphy DJ, Schamberger MS,. Value of plasma b-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients. Am J Cardiol 2005: 95: 909-911. (Pubitemid 40386814)
13. Segal JB, Kasper EK, Rohde C, et al., Coagulation markers predicting cardiac transplant rejection. Transplantation 2001: 72: 233-237. (Pubitemid 32729340)
14. Deng MC, Eisen HJ, Mehra MR, et al., Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006: 6: 150-160. (Pubitemid 43382213)
15. Pham MX, Teuteberg JJ, Kfoury AG, et al., Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010: 362: 1890-1900.
16. Pemberton CJ, Johnson ML, Yandle ML, Espiner EA,. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000: 36: 355-359.
17. Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, De Bold AJ,. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999: 100: 287-291. (Pubitemid 29340136)
18. Meirovich YF, Veinot JP, De Bold MLK, et al., Relationship between natriuretic peptides and inflammation: Proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 2008: 27: 31-37.
19. Rossano JW, Denfield SW, Kim JJ, et al., B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant recipients. J Heart Lung Transplant 2008: 27: 649-654.
20. Wong DTH, George K, Wilson J, et al., Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure. Am J Cardiol 2011: 107: 573-578.